Junlei Jia

This inventor holds 5 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Suncadia Pharmaceuticals Co., Ltd.. Active years: 2018-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junlei Jia. Retrieved from https://idiyas.com/inventor/junlei-jia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 5 (Patent Applications = 2)

% Patents Active = 60.0

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

5 out of 159

Jiangsu Hengrui Medicine Company Ltd.

patents

1 out of 2

Suncadia Pharmaceuticals Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2018-2022

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11306085 - Method for preparing pyrimidone heteroaryl derivative and intermediate of pyrimidone heteroaryl derivative (2022-04-19),

2. 10787451 - Crystalline form of GnRH receptor antagonist and preparation method therefor (2020-09-29),

3. 10160759 - Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor (2018-12-25),

4. 10118911 - P-toluenesulfonate for MEK kinase inhibitor, and crystal form thereof and preparation method therefor (2018-11-06),

5. 10030018 - Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor (2018-07-24),

Title: Junlei Jia: Innovator in Pharmaceutical Chemistry

Introduction

Junlei Jia is a prominent inventor based in Jiangsu, China, known for his contributions to pharmaceutical chemistry. He holds a total of 5 patents, showcasing his innovative approach to drug development and synthesis.

Latest Patents

Among his latest patents is a method for preparing pyrimidone heteroaryl derivatives, which includes an intermediate of the pyrimidone heteroaryl derivative. This invention focuses on a specific formula that enhances the efficiency of drug synthesis. Another significant patent involves a crystalline form of a GnRH receptor antagonist and its preparation method. This invention provides a crystalline form I of a specific compound and outlines its use in pharmaceutical compositions aimed at treating diseases associated with GnRH receptor antagonists.

Career Highlights

Junlei Jia has worked with notable companies in the pharmaceutical industry, including Jiangsu Hengrui Medicine Company Ltd. and Suncadia Pharmaceuticals Co., Ltd. His work in these organizations has contributed to advancements in drug formulation and development.

Collaborations

Throughout his career, Junlei has collaborated with esteemed colleagues such as Xiaohui Gao and Guaili Wu. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Junlei Jia's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant innovator in the field. His work continues to impact drug development and improve therapeutic options for various medical conditions.

Profile summary based on public USPTO records.